Loading…

Soluble CD137 and risk of hepatocellular carcinoma: nested case-control studies in cohorts in Shanghai and Singapore

The majority of hepatocellular carcinoma (HCC) cases occur in the presence of cirrhosis. Biomarkers of cirrhosis-associated immune dysfunction such as CD8+ T cell cytokines could aid HCC risk assessment. CD8+ T cell cytokines were determined in pre-diagnostic serum in two studies including 315 HCC c...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2023-06, Vol.128 (11), p.2081-2088
Main Authors: Thomas, Claire E, Adibi, Jennifer J, Kuipers, Allison L, Diergaarde, Brenda, Luu, Hung N, Jin, Aizhen, Koh, Woon-Puay, Gao, Yu-Tang, Adams-Haduch, Jennifer, Wang, Renwei, Lokshin, Anna, Behari, Jaideep, Yuan, Jian-Min
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The majority of hepatocellular carcinoma (HCC) cases occur in the presence of cirrhosis. Biomarkers of cirrhosis-associated immune dysfunction such as CD8+ T cell cytokines could aid HCC risk assessment. CD8+ T cell cytokines were determined in pre-diagnostic serum in two studies including 315 HCC case-control pairs in the Shanghai Cohort Study (SCS) and 197 pairs in the Singapore Chinese Health Study (SCHS). Conditional logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (CI) for HCC with levels of five cytokines-soluble CD137 (sCD137), soluble Fas (sFas), perforin, macrophage inflammatory protein 1-beta (MIP-1β), and tumour necrosis factor alpha (TNF-α). sCD137 levels were significantly higher in HCC cases than controls in both cohorts (Ps 
ISSN:0007-0920
1532-1827
DOI:10.1038/s41416-023-02223-z